942155-69-3

Upstream product

• 942155-68-2 2D-(2,3/4,5)-2,3,4-tri-O-benzyl-5-O-(tert-butyldimethylsilyl)tetrahydroxycyclohexanone 
• 174851-25-3 (2R,3R,4S,5S)-2,3,4-Tris-benzyloxy-5-hydroxy-cyclohexanone 

Downstream Products

• 942155-70-6 tert-butyldimethylsilyl 2,3,4-tri-O-benzyl-5a-carba-α-D-galactopyranoside 
• 924298-44-2 (1S,2S,3S,4S,5R)-2,3,4-tris(benzyloxy)-5-((benzyloxy)methyl)cyclohexan-1-ol 
• 942155-71-7 tert-butyldimethylsilyl 2,3,4,6-tetra-O-benzyl-5a-carba-α-D-galactopyranoside 
• 942155-72-8 (2S,3S,4R)-1-O-(2,3,4,6-tetra-O-benzyl-5a-carba-α-D-galactopyranosyl)-2-N-benzylamino-3,4-O-isopropylideneoctadecane-1,3,4-triol 
• 942155-73-9 (2S,3S,4R)-2-N-benzylamino-1-O-(2,3,4,6-tetra-O-benzyl-5a-carba-α-D-galactopyranosyl)octadecane-1,3,4-triol 
• 942155-74-0 C₂₅H₅₁NO₇ 

Relevant academic research and scientific papers

RCAI-37, 56, 59, 60, 92, 101, and 102, cyclitol and carbasugar analogs of KRN7000: Their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines

Cyclitol [RCAI-37 (1), 59 (5), 92 (7), and 102 (2)] and carbasugar analogs [RCAI-56 (3), 60 (4), and 101 (6)] of KRN7000 were synthesized through coupling reactions of the corresponding cyclitol or carbasugar derivatives with a cyclic sulfamidate (9) as t

RCAI-56, a carbocyclic analogue of KRN7000: its synthesis and potent activity for natural killer (NK) T cells to preferentially produce interferon-γ

RCAI-56 (3), a carbocyclic analogue of KRN7000 (1) was synthesized through an efficient coupling of a carba-α-d-galactose derivative 11 with cyclic sulfamidate derivative 13 of phytosphingosine to give 15. Carbasugar derivative 11 was prepared by starting